Bio-Rad Laboratories - 39 Year Stock Price History | BIO

Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits. The latest closing stock price for Bio-Rad Laboratories as of June 24, 2019 is 301.00.
  • The all-time high Bio-Rad Laboratories stock price is 326.15, which is 8.4% above the current share price.
  • The Bio-Rad Laboratories 52-week high stock price is 326.15, which is 8.4% above the current share price.
  • The Bio-Rad Laboratories 52-week low stock price is 220.10, which is 26.9% below the current share price.
  • The average Bio-Rad Laboratories stock price for the last 52 weeks is 286.83.
Bio-Rad Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 284.1808 228.0800 317.4100 224.3000 301.0000 29.62%
2018 277.5328 241.4200 326.1500 220.1000 232.2200 -2.70%
2017 219.5752 182.9100 271.3000 182.9100 238.6700 30.94%
2016 149.1690 136.1900 183.4600 123.9300 182.2800 31.46%
2015 137.5260 120.3500 151.9300 113.7700 138.6600 15.01%
2014 120.8765 122.6500 133.7300 106.4800 120.5600 -2.47%
2013 118.6682 107.4600 126.0000 107.4600 123.6100 17.67%
2012 102.7218 98.0800 114.2500 92.3000 105.0500 9.38%
2011 108.0200 105.3200 126.3400 87.5400 96.0400 -7.52%
2010 94.7088 97.8700 113.6300 81.5000 103.8500 7.66%
2009 78.5782 74.4700 100.4600 53.1000 96.4600 28.08%
2008 87.1254 99.9700 108.1000 61.5200 75.3100 -27.32%
2007 82.9541 82.2200 107.5700 67.6700 103.6200 25.57%
2006 68.9380 65.4500 84.0100 57.2500 82.5200 26.10%
2005 55.5089 57.1700 66.9000 47.0600 65.4400 14.07%
2004 55.2252 58.4100 61.9000 50.0100 57.3700 -0.52%
2003 48.0377 38.2100 62.1500 33.4000 57.6700 49.02%
2002 39.7467 30.9000 50.5100 28.1250 38.7000 22.27%
2001 23.7924 16.0500 32.5250 15.0750 31.6500 99.06%
2000 12.9794 11.3100 16.7450 10.6250 15.9000 36.01%
1999 12.2611 10.3100 14.5000 9.4400 11.6900 11.33%
1998 13.1470 13.0600 16.8750 9.8750 10.5000 -19.60%
1997 13.5673 15.1900 16.3750 11.8100 13.0600 -12.93%
1996 14.6824 14.2067 18.3100 12.1250 15.0000 5.88%
1995 11.3630 9.1267 14.1667 8.4567 14.1667 53.15%
1994 6.4240 3.5000 9.6267 3.5000 9.2500 177.50%
1993 4.7750 5.7067 5.9167 3.3333 3.3333 -41.59%
1992 6.1821 6.4167 7.1267 5.3733 5.7067 -13.32%
1991 7.0525 6.0833 9.1667 5.5433 6.5833 6.76%
1990 5.8093 5.4167 7.6667 4.2067 6.1667 15.63%
1989 5.6551 5.7067 6.5433 4.7500 5.3333 -5.88%
1988 6.3804 5.2500 7.7067 4.9167 5.6667 11.48%
1987 7.6195 5.8733 10.6667 3.7500 5.0833 -11.59%
1986 5.9524 5.0556 7.6400 4.5556 5.7500 13.74%
1985 3.2334 2.1304 5.3067 2.1304 5.0556 137.31%
1984 2.2033 2.5007 2.5185 2.0741 2.1304 -14.81%
1983 2.3317 1.3511 2.8696 1.3511 2.5007 87.56%
1982 1.3124 1.5378 1.6104 0.8696 1.3333 -7.69%
1981 2.4659 2.9807 3.6667 1.2963 1.4444 -51.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.076B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.955B 29.11
Medtronic (MDT) Ireland $133.284B 19.04
Stryker (SYK) United States $75.636B 26.99
Boston Scientific (BSX) United States $57.976B 27.79
Baxter (BAX) United States $42.043B 26.50
Zimmer Biomet Holdings (ZBH) United States $24.226B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
ResMed (RMD) United States $17.217B 32.90
Canopy Growth (CGC) Canada $13.835B 0.00
Aurora Cannabis (ACB) Canada $7.403B 73.00
Insulet (PODD) United States $7.147B 520.74
Hill-Rom Holdings (HRC) United States $6.992B 21.20
Perrigo (PRGO) Ireland $6.052B 10.23
Haemonetics (HAE) United States $6.021B 49.14
GW Pharmaceuticals (GWPH) United Kingdom $5.237B 0.00
ICU Medical (ICUI) United States $5.130B 30.61
Hutchison China MediTech (HCM) China $3.814B 0.00
Neogen (NEOG) United States $3.238B 52.65
Agios Pharmaceuticals (AGIO) United States $2.981B 0.00
NuVasive (NUVA) United States $2.962B 24.19
National Vision Holdings (EYE) United States $2.499B 53.25
Quidel (QDEL) United States $2.360B 24.49
Aphria (APHA) $1.687B 0.00
Cardiovascular Systems (CSII) United States $1.495B 858.80
Phibro Animal Health (PAHC) United States $1.220B 18.28
AtriCure (ATRC) United States $1.159B 0.00
VAREX IMAGING (VREX) United States $1.119B 23.75
Lantheus Holdings (LNTH) United States $1.081B 28.71
OrganiGram Holdings (OGI) Canada $0.993B 0.00
NanoString Technologies (NSTG) United States $0.935B 0.00
PetIQ (PETQ) United States $0.899B 21.84
Quanterix (QTRX) United States $0.846B 0.00
MacroGenics (MGNX) United States $0.812B 0.00
Omeros (OMER) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.771B 21.61
Cerus (CERS) United States $0.682B 0.00
TG Therapeutics (TGTX) United States $0.638B 0.00
Surmodics (SRDX) United States $0.572B 83.20
OraSure Technologies (OSUR) United States $0.552B 25.40
LeMaitre Vascular (LMAT) United States $0.545B 26.37
Meridian Bioscience (VIVO) United States $0.489B 14.95
Evolus (EOLS) United States $0.371B 0.00
Vapotherm (VAPO) United States $0.364B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.355B 0.00
Zynex (ZYXI) United States $0.355B 36.73
BioLife Solutions (BLFS) United States $0.311B 97.41
Utah Medical Products (UTMD) United States $0.302B 20.93
Bovie Medical (APYX) United States $0.217B 0.00
Cytosorbents (CTSO) United States $0.210B 0.00
Owens & Minor (OMI) United States $0.193B 4.08
Chimerix (CMRX) United States $0.173B 0.00
Rockwell Medical (RMTI) United States $0.172B 0.00
Fonar (FONR) United States $0.140B 7.38
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.111B 0.00
Neurotrope (NTRP) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Surface Oncology (SURF) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 19.21
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Senestech (SNES) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.58
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.73